213 related articles for article (PubMed ID: 37196368)
1. Revealing the structural and molecular interaction landscape of the favipiravir-RTP and SARS-CoV-2 RdRp complex through integrative bioinformatics: Insights for developing potent drugs targeting SARS-CoV-2 and other viruses.
Chakraborty C; Bhattacharya M; Saha A; Alshammari A; Alharbi M; Saikumar G; Pal S; Dhama K; Lee SS
J Infect Public Health; 2023 Jul; 16(7):1048-1056. PubMed ID: 37196368
[TBL] [Abstract][Full Text] [Related]
2. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
Naidu SAG; Mustafa G; Clemens RA; Naidu AS
J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
[TBL] [Abstract][Full Text] [Related]
3. Favipiravir in SARS-CoV-2 Infection: Is it Worth it?
Batiha GE; Moubarak M; Shaheen HM; Zakariya AM; Usman IM; Rauf A; Adhikari A; Dey A; Alexiou A; Hetta HF; Al-Gareeb AI; Al-Kuraishy HM
Comb Chem High Throughput Screen; 2022; 25(14):2413-2428. PubMed ID: 35430987
[TBL] [Abstract][Full Text] [Related]
4. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
Tsuji M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
[TBL] [Abstract][Full Text] [Related]
5. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
Front Immunol; 2022; 13():844749. PubMed ID: 35464436
[TBL] [Abstract][Full Text] [Related]
6. Exploring the structural and molecular interaction landscape of nirmatrelvir and Mpro complex: The study might assist in designing more potent antivirals targeting SARS-CoV-2 and other viruses.
Chakraborty C; Bhattacharya M; Alshammari A; Alharbi M; Albekairi TH; Zheng C
J Infect Public Health; 2023 Dec; 16(12):1961-1970. PubMed ID: 37883855
[TBL] [Abstract][Full Text] [Related]
7. Cyanorona-20: The first potent anti-SARS-CoV-2 agent.
Rabie AM
Int Immunopharmacol; 2021 Sep; 98():107831. PubMed ID: 34247016
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.
Wang Q; Wu J; Wang H; Gao Y; Liu Q; Mu A; Ji W; Yan L; Zhu Y; Zhu C; Fang X; Yang X; Huang Y; Gao H; Liu F; Ge J; Sun Q; Yang X; Xu W; Liu Z; Yang H; Lou Z; Jiang B; Guddat LW; Gong P; Rao Z
Cell; 2020 Jul; 182(2):417-428.e13. PubMed ID: 32526208
[TBL] [Abstract][Full Text] [Related]
9. Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19.
Rafi MO; Bhattacharje G; Al-Khafaji K; Taskin-Tok T; Alfasane MA; Das AK; Parvez MAK; Rahman MS
J Biomol Struct Dyn; 2022 May; 40(8):3711-3730. PubMed ID: 33251975
[TBL] [Abstract][Full Text] [Related]
10. Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp).
Bibi S; Hasan MM; Wang YB; Papadakos SP; Yu H
Curr Med Chem; 2022; 29(1):152-162. PubMed ID: 34420502
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
12. State-of-the-Art Molecular Dynamics Simulation Studies of RNA-Dependent RNA Polymerase of SARS-CoV-2.
Tanimoto S; Itoh SG; Okumura H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142270
[TBL] [Abstract][Full Text] [Related]
13. In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs.
Mondal SK; Mukhoty S; Kundu H; Ghosh S; Sen MK; Das S; Brogi S
Comput Biol Med; 2021 Aug; 135():104591. PubMed ID: 34216889
[TBL] [Abstract][Full Text] [Related]
14. Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2.
Bekheit MS; Panda SS; Girgis AS
Eur J Med Chem; 2023 Apr; 252():115292. PubMed ID: 36965227
[TBL] [Abstract][Full Text] [Related]
15. Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination.
Padhi AK; Dandapat J; Saudagar P; Uversky VN; Tripathi T
FEBS Lett; 2021 Sep; 595(18):2366-2382. PubMed ID: 34409597
[TBL] [Abstract][Full Text] [Related]
16. Two conserved oligomer interfaces of NSP7 and NSP8 underpin the dynamic assembly of SARS-CoV-2 RdRP.
Biswal M; Diggs S; Xu D; Khudaverdyan N; Lu J; Fang J; Blaha G; Hai R; Song J
Nucleic Acids Res; 2021 Jun; 49(10):5956-5966. PubMed ID: 33999154
[TBL] [Abstract][Full Text] [Related]
17. Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico.
Sada M; Saraya T; Ishii H; Okayama K; Hayashi Y; Tsugawa T; Nishina A; Murakami K; Kuroda M; Ryo A; Kimura H
Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33092045
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
Mishra A; Rathore AS
Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
Elfiky AA
J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
[TBL] [Abstract][Full Text] [Related]
20. Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp).
Karthic A; Kesarwani V; Singh RK; Yadav PK; Chaturvedi N; Chauhan P; Yadav BS; Kushwaha SK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]